Injecto Polymers IPO Day 1: Subscribed 0.29x; QIBs lead with 1.02x
- Injecto Polymers IPO subscribed 0.29x on Day 1
- QIB demand surged to 1.02x in late trading
- Retail subscription reached 0.25x
- Issue remains open until September 16, 2026

*this image is generated using AI for illustrative purposes only.
Injecto Polymers IPO subscription accelerated sharply on Day 4, reaching a total of 1.28x. Qualified Institutional Buyers (QIB) drove the momentum, jumping 53.9% intraday from 1.02x to 1.57x in the final hours. Retail investors also pushed their subscription above the fully subscribed mark to 1.26x.
Subscription Status
The Injecto Polymers IPO witnessed a significant surge in demand during the final hours of the bidding window on Day 4. While the first two days saw modest interest, Day 3 triggered a rise in NII and Retail bids, pushing the total to 0.91x. On Day 4, the issue gained further traction, crossing the 1x threshold early and closing at 1.28x.
| Day | Date | QIB | NII (bHNI) | NII (sHNI) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 11-09-2026 | 1.02x | 0.03x | 0.10x | 0.25x | 0.29x |
| Day 2 | 14-09-2026 | 1.02x | 0.03x | 0.10x | 0.25x | 0.29x |
| Day 3 | 15-09-2026 | 1.02x | 0.09x | 1.38x | 0.84x | 0.91x |
| Day 4 | 16-09-2026 | 1.57x | 0.22x | 1.70x | 1.26x | 1.28x |
Intra-day Timeline
Subscription activity picked up pace sharply in the final hours of trading. The total subscription jumped from 0.09x at 14:15 PM to 0.29x by 17:15 PM, driven primarily by institutional investor interest and late retail bids.
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 12:15 | 0.00x | 0.02x | 0.07x | 0.04x |
| 13:15 | 0.00x | 0.02x | 0.08x | 0.06x |
| 14:15 | 0.00x | 0.02x | 0.15x | 0.09x |
| 15:15 | 1.02x | 0.02x | 0.17x | 0.25x |
| 16:15 | 1.02x | 0.03x | 0.20x | 0.27x |
| 17:15 | 1.02x | 0.03x | 0.25x | 0.29x |
Category-wise Breakdown
Qualified Institutional Buyers (QIB) emerged as the strongest category by the end of Day 4, subscribing 1.57 times its quota after a late-day surge. Non-Institutional Buyers (NII) saw the bHNI segment subscribe 1.70 times its quota, while sHNI participation stood at 0.22x. Retail investors showed consistent improvement, rising from 0.25x on Day 1 to 1.26x on Day 4, crossing the fully subscribed threshold. Employee quota remained unsubscribed at 0x.
Offer Details
Injecto Polymers priced its IPO in the band of ₹98.00000 - ₹100.00000. The issue size ranges from ₹235200 to ₹500000. The minimum bid quantity is set at 2400 shares. The bidding window opened on 2026-09-11 and closed on 2026-09-16.
About the Company
Injecto Polymers Limited is a packaging company engaged in manufacturing diverse packaging products including Polypropylene Woven Fabrics, PP Woven Bags, BOPP bags, FIBC bags, and non-woven bags. The company also trades plastic granules and PVC resins. It operates two manufacturing units in West Bengal with a combined installed capacity of 18,070 MT. The company serves customers across agriculture, construction, textiles, chemicals, and consumer goods industries through a B2B model. Promoted by Ramesh Kumar Rateria and Ashok Kumar Rateria, the promoters bring 65 years of combined industry experience.
Financial Highlights
The company reported revenue from operations of ₹375.53 crores for FY26, up from ₹261.48 crores in FY25 and ₹109.05 crores in FY24. Profit before tax stood at ₹23.45 crores in FY26, compared to ₹11.20 crores in FY25 and ₹4.94 crores in FY24.
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue from Operations (₹ crores) | 109.05 | 261.48 | 375.53 |
| Profit Before Tax (₹ crores) | 4.94 | 11.20 | 23.45 |
| Total Assets (₹ crores) | 121.25 | 170.57 | 270.93 |
Objects of the Issue
The company plans to utilize the proceeds for the following purposes:
- Funding Capital expenditure for Phase IV expansion at existing manufacturing facility: ₹30.50 crores
- Repayment/pre-payment of certain outstanding borrowings: ₹10.00 crores
- General Corporate Purposes: Balance proceeds
Risk Factors
- High Customer Concentration: Top 10 customers contributed 40.07% of FY26 revenue.
- Dependence on Trading Activities: Trading contributed 50.36% of FY26 revenue.
- Geographic Concentration: 85.27% of FY26 revenue generated from West Bengal.
- Raw Material Supply and Price Volatility: Dependency on polypropylene and other raw materials.
- Negative Operating Cash Flows: Reported negative operating cash flows in FY24, FY25, and FY26.
What's Next
Allotment is scheduled for 2026-09-17. The shares are expected to list on 2026-09-21.
Will the late-day surge in QIB demand sustain through the remaining bidding days, or is it indicative of price-sensitive institutional interest?
How might Injecto Polymers' heavy reliance on trading activities (over 50% of revenue) impact investor confidence in its long-term manufacturing growth story?
Given the negative operating cash flows over the last three years, how will investors assess the company's ability to service debt post-IPO despite the proposed repayment of ₹10 crores?
























